webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

EGGGG-PEG8-amide-bis(deoxyglucitol)

  CAS No.: 2842855-38-1   Cat No.: BADC-01749 4.5  

EGGGG-PEG8-amide-bis(deoxyglucitol) is a hydrophilic ADC linker with PEG8 spacer and sugar-based protective groups, enhancing solubility and biocompatibility for efficient payload conjugation in antibody-drug conjugates. Keywords: ADC linker, PEG linker, hydrophilic linker, sugar derivatives, payload conjugation.

EGGGG-PEG8-amide-bis(deoxyglucitol)

Structure of 2842855-38-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C49H91N9O28
Molecular Weight
1254.29

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(4S)-4-amino-5-[[2-[[2-[[2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[3-[[(2S)-1,5-dioxo-1,5-bis[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid
Canonical SMILES
C(CC(=O)O)C(C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NC(CCC(=O)NCC(C(C(C(CO)O)O)O)O)C(=O)NCC(C(C(C(CO)O)O)O)O)N
InChI
InChI=1S/C49H91N9O28/c50-31(1-4-43(71)72)48(77)57-28-42(70)55-27-41(69)54-26-40(68)53-25-39(67)51-6-8-80-10-12-82-14-16-84-18-20-86-22-21-85-19-17-83-15-13-81-11-9-79-7-5-38(66)58-32(49(78)56-24-34(62)45(74)47(76)36(64)30-60)2-3-37(65)52-23-33(61)44(73)46(75)35(63)29-59/h31-36,44-47,59-64,73-76H,1-30,50H2,(H,51,67)(H,52,65)(H,53,68)(H,54,69)(H,55,70)(H,56,78)(H,57,77)(H,58,66)(H,71,72)/t31-,32-,33-,34-,35+,36+,44+,45+,46+,47+/m0/s1
InChIKey
SRJGEXWUUWWJCQ-OJWWGKDHSA-N

EGGGG-PEG8-amide-bis(deoxyglucitol) is a versatile chemical compound with diverse applications in advanced bioscience. Here are four key applications:

Drug Delivery Systems: Unleashing the potential of EGGGG-PEG8-amide-bis(deoxyglucitol), researchers can revolutionize drug delivery, enhancing the stability and efficacy of therapeutic agents. The PEG component enhances drug solubility and bioavailability, making it a crucial element in nanoparticle-based drug delivery systems. By enabling targeted and sustained drug release, this compound plays a pivotal role in optimizing medication delivery strategies for maximal efficacy.

Bioconjugation: EGGGG-PEG8-amide-bis(deoxyglucitol) stands as a cornerstone in bioconjugation methodologies, offering a versatile platform for attaching a myriad of biomolecules, from peptides to proteins and antibodies to drug carriers or functional groups. With its multiple reactive sites, this compound facilitates flexible conjugation techniques, laying the groundwork for the creation of highly specific and functional biomaterials customized for diagnostics and therapeutic interventions with unparalleled precision, opening new avenues for advanced bioconjugation strategies.

Medical Imaging: Embracing the versatility of EGGGG-PEG8-amide-bis(deoxyglucitol), researchers can pioneer advancements in medical imaging by designing contrast agents that enhance imaging diagnostics. With its biocompatible and hydrophilic properties, this compound improves the circulation time and reduces the immunogenicity of imaging agents, thereby boosting the sensitivity and accuracy of modalities like MRI and CT.

Targeted Drug Delivery: Capitalizing on its ability to link targeting moieties, such as ligands or antibodies, EGGGG-PEG8-amide-bis(deoxyglucitol) empowers the development of targeted drug delivery systems. This strategic approach ensures the precise delivery of therapeutics to specific cells or tissues, minimizing off-target effects and maximizing therapeutic outcomes. Such targeted delivery strategies are essential in the realm of disease treatment, particularly in diseases like cancer, where precision and efficacy are paramount for successful treatment outcomes.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: PROTAC BRD4 Degrader-9 | PROTAC BRD4 Degrader-13 | DBCO-PEG4-Val-Cit-PAB-PNP | Mal-di-PEG-Val-Cit-PAB | NH2-PEG4-Val-Cit-PAB-OH | SCO-PEG3-NH2 | Boc-PEG2-Val-Cit-PAB-OH | NH2-PEG3-Val-Cit-PAB-OH | Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) | NH2-PEG1-Val-Cit-PAB-OH | EGGGG-PEG8-amide-bis(deoxyglucitol)
Send Inquiry
Verification code
Inquiry Basket